XL-647

• Description:

  XL-647 (Tesevatinib, EXEL-7647, KD-019) is a novel spectrum-selective kinase inhibitor that potently inhibits the EGFR, ErbB2, KDR and EphB4 with IC50 of 0.3, 16, 1.5 and 1.4 nM, respectively.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  491.4

• Molecular Formula:

  C24H25Cl2FN4O2

• Notes:

  Research use only, not for human use.

• Receptor:

  EGFR

• CAS Number:

  781613-23-8